Efficacy and Safety of 9MW0813 in Subjects With Diabetic Macular Edema

NCT05324774 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

346

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: 9MW0813
DRUG: Aflibercept

Sponsor

Mabwell (Shanghai) Bioscience Co., Ltd.